Developer of genetically targeted intervention therapy for age-related diseases. Its technology is based on removing the cells that have entered a non-dividing condition and turns into senescent (zombie) cells. These cells secrete molecules that cause inflammation leading to a large number of age-related diseases.
← All startups
Oisín Biotechnologies
Series ADeveloper of genetically targeted intervention therapy for age-related diseases. Its technology is based on removing the cells that have entered a non-dividing condition and turns into senescent (zombie) cells. These cells secrete molecules that cause inflammation leading to a large number of age-related diseases.
About
Institutional investors
Forever HealthyKizooMethuselah FoundationAlthea GroupAbbVieMethuselah FundsHedgewoodLuminous Futures
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.
Similar startups
Raising like Oisín Biotechnologies?
Analyze your pitch deck before your next raise.
Analyze My Deck →